Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
10/28/1999 | WO1999054442A1 Protein phosphatase methylesterase dna |
10/28/1999 | WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use |
10/28/1999 | WO1999053762A1 A method for efficient and highly selective control of microorganisms |
10/28/1999 | WO1999045125A3 Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens |
10/28/1999 | WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
10/28/1999 | WO1999037787A3 Human orthologues of wart |
10/28/1999 | WO1999028446A3 Branched chain amino acid biosynthetic enzymes |
10/28/1999 | WO1999027080A3 Human protein kinase and kinase inhibitors |
10/28/1999 | WO1999021971A3 Thermostable alcohol dehydrogenases |
10/28/1999 | DE19903693A1 Protease zur Aktivierung des Gerinnungsfaktors VII Protease for activation of coagulation factor VII |
10/28/1999 | DE19817118C1 New nucleic acid encoding human dyskerin, for diagnosis, treatment and prevention of dyskeratosis congenita and for stabilizing chromosomes |
10/28/1999 | CA2658218A1 Improved immunodiagnostic assays using reducing agents |
10/28/1999 | CA2330839A1 Gene of rice dihydrodipicolinate synthase and dna relating to the same |
10/28/1999 | CA2328967A1 A method for efficient and highly selective control of microorganisms |
10/28/1999 | CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use |
10/28/1999 | CA2326823A1 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
10/28/1999 | CA2326725A1 Method for synthesizing dna |
10/28/1999 | CA2326384A1 Canine erythropoietin gene and recombinant protein |
10/28/1999 | CA2325871A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep |
10/28/1999 | CA2324442A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata |
10/28/1999 | CA2269103A1 Peptides binding to bone marrow stromal cell antigen |
10/27/1999 | EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase |
10/27/1999 | EP0952223A1 REGULATORY SEQUENCE OF CELLULASE cbh1 GENES ORIGINATING IN TRICHODERMA VIRIDE AND SYSTEM FOR MASS-PRODUCING PROTEINS OR PEPTIDES THEREWITH |
10/27/1999 | EP0952222A1 Transgenic plants presenting a modified inulin producing profile |
10/27/1999 | EP0952221A2 L-Glutamic acid-producing bacterium and method for producing L-glutamic acid |
10/27/1999 | EP0952215A2 Protease for activating clotting factor VII |
10/27/1999 | EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase |
10/27/1999 | EP0951561A1 Enzymatic processes for preparing (s)-cyanohydrins |
10/27/1999 | EP0951556A2 Disease associated protein tyrosine phosphatases |
10/27/1999 | EP0951546A2 Compositions and methods of use for osteoclast inhibitory factors |
10/27/1999 | EP0951544A2 Methods for administration of recombinant gene delivery vehicles for treatment of human disease |
10/27/1999 | EP0951540A2 Antisense nucleic acids and hammerhead ribozymes |
10/27/1999 | EP0951538A2 PARTIAL SEQUENCES OF PURINE BIOSYNTHESIS GENES FROM $i(ASHBYA GOSSYPII) AND THEIR USE IN THE MICROBIAL RIBOFLAVIN SYNTHESIS |
10/27/1999 | EP0951534A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
10/27/1999 | EP0951528A2 Detergent compositions containing isopeptidase |
10/27/1999 | EP0951471A1 Cycloalkyl inhibitors of protein farnesyltransferase |
10/27/1999 | EP0951469A1 Novel compounds |
10/27/1999 | EP0951295A1 Methods and compositions useful for inhibition of angiogenesis |
10/27/1999 | EP0951272A1 An oral care product comprising a mutan binding domain |
10/27/1999 | EP0695353A4 Selecting genes encoding catalytic antibodies |
10/27/1999 | EP0641785B1 Triazolylated tertiary amine compound or salt thereof |
10/27/1999 | EP0590082B1 Antisense oligonucleotide inhibition of the ras gene |
10/27/1999 | CN1233290A Antifungal proteins, DNA coding therefore, and hosts incorporating same |
10/27/1999 | CN1233286A Alpha-amylase fused to cellulose binding domain, for starch degradation |
10/27/1999 | CN1232872A Overproduction of riboflavin in yeast |
10/27/1999 | CN1232622A Beverage antioxidant system |
10/27/1999 | CN1045996C Processfor producing ethanol |
10/27/1999 | CN1045995C Method of inducing lysine overproduction in plants |
10/26/1999 | US5973230 Pinosylvine synthase genes |
10/26/1999 | US5973229 Isolated, purified protein encoding cdna; to alter plant's sensitivity to certain herbicides |
10/26/1999 | US5973228 Coniferin beta-glucosidase cDNA for modifying lignin content in plants |
10/26/1999 | US5973226 Method of changing the composition of the phospholipid produced by the living body and recombinant vector therefor |
10/26/1999 | US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators |
10/26/1999 | US5973110 Inhibiting the bio-activity of enzymes. |
10/26/1999 | US5972901 Making a composition for delivering an oligonucleotide to a mammalian cell by providing a peptide target binding moiety being capable of binding to a serpin enzyme complex receptor, polylysine, an oligonucleotide vector; conjugating, coupling |
10/26/1999 | US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering |
10/26/1999 | US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis |
10/26/1999 | US5972873 4-substituted-phenyl-boronic acids as enzyme stabilizers |
10/26/1999 | US5972872 Enzyme preparation with cellulytic activity |
10/26/1999 | US5972701 Nucleotide sequence of ribo- or deoxyribonucleotides which may have modified sugars, bases, or phosphates; for hybridization and cleavage of rna targets; treatment of disease |
10/26/1999 | US5972698 Tryptase is expressed virtually exclusively by mast cells. |
10/26/1999 | US5972697 NIMA interacting proteins |
10/26/1999 | US5972690 DNA strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls |
10/26/1999 | US5972684 Nucleic acid and amino acid sequences of a novel carbonic anhydrase isoform and to the use of these sequences in the diagnosis, prevention, or treatment of circulatory and neuronal diseases, inflammation, and cancer |
10/26/1999 | US5972683 Mutant type subtilisin YaB and its application |
10/26/1999 | US5972682 Enzymatically active modified subtilisins |
10/26/1999 | US5972681 Calcium-requiring prothrombin activator |
10/26/1999 | US5972680 An aminopeptidase which is involved in insulin regulation. |
10/26/1999 | US5972679 The identification and isolation of extracellular polypeptides which are associated with plant frost or cold tolerance and their use in mitigating the effects of frost and controlling crystalline growth of ice. |
10/26/1999 | US5972678 Animal 2-5A dependent RNases |
10/26/1999 | US5972677 Allow for internal initiation of mrna cap-independent translation. |
10/26/1999 | US5972676 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
10/26/1999 | US5972675 A molecular target for therapeutic intervention and/or as a therapeutic tool for diagnosing and treating breast and/or ovarian cancer. |
10/26/1999 | US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade. |
10/26/1999 | US5972673 Enzyme for phage resistance |
10/26/1999 | US5972672 Phanerochaete chrysospoirium strains CNCM I-1511, I-1512 and I-1513 for producing lignin peroxidase and manganese peroxidase |
10/26/1999 | US5972671 Fructosyl amino acid oxidase and process for producing the same |
10/26/1999 | US5972670 Blue copper oxidase mutants with enhanced activity |
10/26/1999 | US5972669 Salt-stabilized enzyme preparations |
10/26/1999 | US5972668 Production of multi-enzyme granules |
10/26/1999 | US5972667 Applicable to the temperature-sensitive transformation of cells with the specific synthesis or activation of bio-molecules such as enzymes and/or structural heat shock proteins. |
10/26/1999 | US5972666 Assembly-deficient herpesvirus vaccine |
10/26/1999 | US5972665 Pyrodictium pullulanase |
10/26/1999 | US5972664 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
10/26/1999 | US5972660 Human hydroxypyruvate reductase |
10/26/1999 | US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor |
10/26/1999 | US5972645 Flea serine protease nucleic acid molecules |
10/26/1999 | US5972644 Cyanobacterial and plant acetyl-CoA carboxylase |
10/26/1999 | US5972636 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
10/26/1999 | US5972616 TADG-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas |
10/26/1999 | US5972609 Utrophin gene promotor |
10/26/1999 | US5972607 Methods for nucleic acid amplification with thermostable ribonuclease H |
10/26/1999 | US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease; |
10/26/1999 | US5972605 Assays for regulators of mammalian telomerase expression |
10/26/1999 | US5972603 DNA polymerase with modified processivity |
10/26/1999 | US5972599 High affinity nucleic acid ligands of cytokines |
10/26/1999 | US5972353 Immunogenic amount of an immunologically active mn protein or m polypeptide effective to immunize a vertebrate against a neoplastic disease associated with expression of mn antigen |
10/26/1999 | US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents |
10/26/1999 | US5972336 Urease-based vaccine against helicobacter infection |
10/26/1999 | US5972334 Vaccines for treatment of lymphoma and leukemia |